[ad_1]
Scientists from different countries are working day and night to find a vaccine that protects humanity from the coronavirus. Johnson & Johnson, an American multinational company, has come a long way in the race to make vaccines. But recently the company played a big boost in vaccine testing.
Meanwhile, Johnson & Johnson has been forced to suspend trials of a possible coronavirus vaccine. A volunteer got sick and had to take that step. However, it is not yet clear what kind of disease has occurred in your body.
Late last month, the company began a third phase of large-scale trials in the United States with 60,000 volunteers. At the time, Johnson said, the experimental vaccine had been shown to develop strong immunity.
A tentative result of the vaccine trial was also published at that time. According to the results, the first and second steps of this possible coronary vaccine have yielded the expected results. In both cases there is a complete digestive tract.
But Johnson & Johnson has decided to temporarily suspend all trials after a volunteer who recently received the vaccine suddenly fell ill.
Not only that, the online registration system for recruiting new volunteers has also been discontinued. In addition, an independent organization has been commissioned to review all information and statistics related to volunteer safety.
Johnson said investigators had been instructed to suspend the trial after reports emerged that the volunteer was ill. However, no details were provided.
The agency says it is important to keep the volunteer’s identity private. Furthermore, nothing can be said without verifying the information about the volunteer’s illness.
Researchers say that these clinical trials can create some adverse conditions. Some people may suffer from weakness and illness. This is not unusual.
A statement from Johnson & Johnson stated: “We have temporarily suspended all trials of the Covid-19 vaccine, including our third trial, due to the illness of a volunteer.”
In addition to more than two hundred locations in the United States, Johnson & Johnson was conducting large-scale vaccine trials in Argentina, Brazil, Chile, Colombia, Mexico, Peru, and South Africa.
Previously, a trial of the Oxford vaccine was canceled due to a side effect on a volunteer’s body. Later, however, Oxford reported relief. The testing process was subsequently resumed.
The coronavirus vaccine is being developed by a team of scientists from the University of Oxford and the pharmaceutical company AstraZeneca. According to UK media reports, the Oxford vaccine could be approved by the country’s health department later this year.
This potential corona vaccine is likely to arrive this year. A source has expressed hope that the vaccine can be released in 6 months or sooner.
The third phase of the vaccine is currently being tested. The UK Joint Vaccine Committee has developed a special protocol. He said any approved vaccine would be given first to people 65 and older. In addition, it will be administered to those who have some other disease or are at high risk. Then there will be fifty. This vaccine will be given to the youth at the end of everything.
TTN
The corona virus has changed our lives. Time is spent in joy, pain, crisis, anxiety. How are you spending your time? You can write in Jago News. Ship Today – [email protected]
[ad_2]
